Mitoribosome insufficiency in β cells is associated with type 2 diabetes-like islet failure
2
조회
0
다운로드
4
인용
0
참고문헌
초록
Genetic variations in mitoribosomal subunits and mitochondrial transcription factors are related to type 2 diabetes. However, the role of islet mitoribosomes in the development of type 2 diabetes has not been determined. We investigated the effects of the mitoribosomal gene on β-cell function and glucose homeostasis. Mitoribosomal gene expression was analyzed in datasets from the NCBI GEO website (GSE25724, GSE76894, and GSE76895) and the European Nucleotide Archive (ERP017126), which contain the transcriptomes of type 2 diabetic and nondiabetic organ donors. We found deregulation of most mitoribosomal genes in islets from individuals with type 2 diabetes, including partial downregulation of CRIF1. The phenotypes of haploinsufficiency in a single mitoribosomal gene were examined using β-cell-specific Crif1 (Mrpl59) heterozygous-deficient mice. Crif1beta+/− mice had normal glucose tolerance, but their islets showed a loss of first-phase glucose-stimulated insulin secretion. They also showed increased β-cell mass associated with higher expression of Reg family genes. However, Crif1beta+/− mice showed earlier islet failure in response to high-fat feeding, which was exacerbated by aging. Haploinsufficiency of a single mitoribosomal gene predisposes rodents to glucose intolerance, which resembles the early stages of type 2 diabetes in humans.
Abstract
Genetic variations in mitoribosomal subunits and mitochondrial transcription factors are related to type 2 diabetes. However, the role of islet mitoribosomes in the development of type 2 diabetes has not been determined. We investigated the effects of the mitoribosomal gene on β-cell function and glucose homeostasis. Mitoribosomal gene expression was analyzed in datasets from the NCBI GEO website (GSE25724, GSE76894, and GSE76895) and the European Nucleotide Archive (ERP017126), which contain the transcriptomes of type 2 diabetic and nondiabetic organ donors. We found deregulation of most mitoribosomal genes in islets from individuals with type 2 diabetes, including partial downregulation of CRIF1. The phenotypes of haploinsufficiency in a single mitoribosomal gene were examined using β-cell-specific Crif1 (Mrpl59) heterozygous-deficient mice. Crif1beta+/− mice had normal glucose tolerance, but their islets showed a loss of first-phase glucose-stimulated insulin secretion. They also showed increased β-cell mass associated with higher expression of Reg family genes. However, Crif1beta+/− mice showed earlier islet failure in response to high-fat feeding, which was exacerbated by aging. Haploinsufficiency of a single mitoribosomal gene predisposes rodents to glucose intolerance, which resembles the early stages of type 2 diabetes in humans.
참고문헌 (55)
- Maechler, P., "Mitochondrial function in normal and diabetic beta-cells", Nature, 414, pp.807~812 (2001)
- Hatefi, Y., "The mitochondrial electron transport and oxidative phosphorylation system", Annu. Rev. Biochem, 54, pp.1015~1069 (1985)
- Rackham, O., "The human mitochondrial transcriptome and the RNA-binding proteins that regulate its expression", Wiley Interdiscip. Rev. RNA, 3, pp.675~695 (2012)
- Pearce, S. F., "Regulation of mammalian mitochondrial gene expression:recent advances", Trends Biochem. Sci, 42, pp.625~639 (2017)
- Ott, M., "Organization and regulation of mitochondrial protein synthesis", Annu. Rev. Biochem, 85, pp.77~101 (2016)
- Greber, B. J., "Structure and function of the mitochondrial ribosome", Annu. Rev. Biochem, 85, pp.103~132 (2016)
- Sylvester, J. E., "Mitochondrial ribosomal proteins : candidate genes for mitochondrial disease", Genet. Med, 6, pp.73~80 (2004)
- De Silva, D., "Mitochondrial ribosome assembly in health and disease", Cell Cycle, 14, pp.2226~2250 (2015)
- Kim, H. J., "Mitochondrial ribosomes in cancer", Semin. Cancer Biol, 47, pp.67~81 (2017)
- Greber, B. J., "Ribosome. The complete structure of the 55S mammalian mitochondrial ribosome", Science, 348, pp.303~308 (2015)
- Kim, S. J., "CRIF1 is essential for the synthesis and insertion of oxidative phosphorylation polypeptides in the mammalian mitochondrial membrane", Cell Metab, 16, pp.274~283 (2012)
- Kim, Y. K., "Disruption of CR6-interacting factor-1(CRIF1)in mouse islet beta cells leads to mitochondrial diabetes with progressive beta cell failure", Diabetologia, 58, pp.771~780 (2015)
- Kim, K., "Degradation of PHLPP2 by KCTD17, via a glucagon-dependent pathway, promotes hepatic steatosis", Gastroenterology, 153, pp.1568~1580.e1510 (2017)
- Segerstolpe, A., "Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes", Cell Metab, 24, pp.593~607 (2016)
- Kwon, M. C., "Crif1 is a novel transcriptional coactivator of STAT3", EMBO J, 27, pp.642~653 (2008)
- Brouwers, B., "Impaired islet function in commonly used transgenic mouse lines due to human growth hormone minigene expression", Cell Metab, 20, pp.979~990 (2014)
- Li, D. S., "A protocol for islet isolation from mouse pancreas", Nat. Protoc, 4, pp.1649~1652 (2009)
- Wikstrom, J. D., "A novel high-throughput assay for islet respiration reveals uncoupling of rodent and human islets", PLoS ONE, 7, pp.e33023~ (2012)
- Dominguez, V., "Class II phosphoinositide 3-kinase regulates exocytosis of insulin granules in pancreatic beta cells", J. Biol. Chem, 286, pp.4216~4225 (2011)
- Solimena, M., "Systems biology of the IMIDIA biobank from organ donors and pancreatectomised patients defines a novel transcriptomic signature of islets from individuals with type 2 diabetes", Diabetologia, 61, pp.641~657 (2018)
- Cheadle, C., "Analysis of microarray data using Z score transformation", J. Mol. Diagn, 5, pp.73~81 (2003)
- Zwiener, I., "Transforming RNA-Seq data to improve the performance of prognostic gene signatures", PLoS ONE, 9, pp.e85150~ (2014)
- Marselli, L., "Persistent or transient human beta cell dysfunction induced by metabolic stress : specific signatures and shared gene expression with Type 2diabetes", Cell Rep, 33, pp.108466~ (2020)
- Supale, S., "Loss of prohibitin induces mitochondrial damages altering betacell function and survival and is responsible for gradual diabetes development", Diabetes, 62, pp.3488~3499 (2013)
- Sharoyko, V. V., "Loss of TFB1M results in mitochondrial dysfunction that leads to impaired insulin secretion and diabetes", Hum. Mol. Genet, 23, pp.5733~5749 (2014)
- Silva, J. P., "Impaired insulin secretion and beta-cell loss in tissue-specific knockout mice with mitochondrial diabetes", Nat. Genet, 26, pp.336~340 (2000)
- Ahren, J., "Increased beta-cell volume in mice fed a high-fat diet : a dynamic study over 12 months", Islets, 2, pp.353~356 (2010)
- Hull, R. L., "Dietary-fat-induced obesity in mice results in beta cell hyperplasia but not increased insulin release: evidence for specificity of impaired beta cell adaptation", Diabetologia, 48, pp.1350~1358 (2005)
- Sone, H., "Pancreatic beta cell senescence contributes to the pathogenesis of type 2 diabetes in high-fat diet-induced diabetic mice", Diabetologia, 48, pp.58~67 (2005)
- Davies, M. J., "Loss of the first phase insulin response to intravenous glucose in subjects with persistent impaired glucose tolerance", Diabetes Med, 11, pp.432~436 (1994)
- Cerasi, E., "The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus", Acta Endocrinol, 55, pp.278~304 (1967)
- Ebrahimi, A. G., "Beta cell identity changes with mild hyperglycemia: implications for function, growth, and vulnerability", Mol. Metab, 35, pp.100959~ (2020)
- Liesa, M., "Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure", Cell Metab, 17, pp.491~506 (2013)
- Ghanemi, A., "Broken energy homeostasis and obesity pathogenesis : the surrounding concepts", J. Clin. Med, 7, pp.453~ (2018)
- Tseng, Y. H., "Cellular bioenergetics as a target for obesity therapy", Nat. Rev. Drug Discov, 9, pp.465~482 (2010)
- Ritz, P., "Mitochondrial function, energy expenditure, aging and insulin resistance", Diabetes Metab, 31(2), pp.5S67~65S73 (2005)
- Pedersen, M. G., "Calcium signaling and secretory granule pool dynamics underlie biphasic insulin secretion and its amplification by glucose : experiments and modeling", Am. J. Physiol. Endocrinol. Metab, 316, pp.E475~E486 (2019)
- Seino, S., "Dynamics of insulin secretion and the clinical implications for obesity and diabetes", J. Clin. Investig, 121, pp.2118~2125 (2011)
- Gandasi, N. R., "Glucose-dependent granule docking limits insulin secretion and is decreased in human Type 2 diabetes", Cell Metab, 27, pp.470~478.e474 (2018)
- Daniel, S., "Identification of the docked granule pool responsible for the first phase of glucose-stimulated insulin secretion", Diabetes, 48, pp.1686~1690 (1999)
- Del Prato, S., "The importance of first-phase insulin secretion : implications for the therapy of type 2 diabetes mellitus", Diabetes Metab. Res. Rev, 17, pp.164~174 (2001)
- Ostenson, C. G., "Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients", Diabetes, 55, pp.435~440 (2006)
- Nagamatsu, S., "Decreased expression of t-SNARE, syntaxin 1, and SNAP-25 in pancreatic beta-cells is involved in impaired insulin secretion from diabetic GK rat islets: restoration of decreased t-SNARE proteins improves impaired insulin secretion", Diabetes, 48, pp.2367~2373 (1999)
- Thurmond, D. C., "Recent insights into beta-cell exocytosis in Type 2 diabetes", J. Mol. Biol, 432, pp.1310~1325 (2020)
- Rorsman, P., "Regulation of calcium in pancreatic alpha-and beta-cells in health and disease", Cell Calcium, 51, pp.300~308 (2012)
- Schulla, V., "Impaired insulin secretion and glucose tolerance in beta cellselective Ca(v)1.2 Ca2+ channel null mice", EMBO J, 22, pp.3844~3854 (2003)
- Parikh, A., "Regenerating proteins and their expression, regulation and signaling", Biomol. Concepts, 3, pp.57~70 (2012)
- Li, Q., "Reg2 expression is required for pancreatic islet compensation in response to aging and high-fat diet-induced obesity", Endocrinology, 158, pp.1634~1644 (2017)
- Planas, R., "Reg(regenerating)gene overexpression in islets from non-obese diabetic mice with accelerated diabetes : role of IFNbeta", Diabetologia, 49, pp.2379~2387 (2006)
- Ji, Y., "Toll-like receptors TLR2 and TLR4 block the replication of pancreatic beta cells in diet-induced obesity", Nat. Immunol, 20, pp.677~686 (2019)
- Chen, Z., "Four decades after the discovery of Regenerating Islet-Derived (Reg) proteins: current understanding and challenges", Front. Cell Dev. Biol, 7, pp.235~ (2019)
- Wojtusciszyn, A., "Insulin secretion from human beta cells is heterogeneous and dependent on cell-to-cell contacts", Diabetologia, 51, pp.1843~1852 (2008)
- Pipeleers, D., "Glucose-induced insulin release depends on functional cooperation between islet cells", Proc. Natl Acad. Sci. USA, 79, pp.7322~7325 (1982)
- Kharouta, M., "No mantle formation in rodent islets—the prototype of islet revisited", Diabetes Res. Clin. Pract, 85, pp.252~257 (2009)
- Kilimnik, G., "Altered islet composition and disproportionate loss of large islets in patients with type 2 diabetes", PLoS ONE, 6, pp.e27445~ (2011)
